Leading Pharmaceutical Operational Excellence, Softcover reprint of the original 1st ed. 2013
Outstanding Practices and Cases

Language: English
Cover of the book Leading Pharmaceutical Operational Excellence

Subject for Leading Pharmaceutical Operational Excellence

163.51 €

In Print (Delivery period: 15 days).

Add to cartAdd to cart
Leading Pharmaceutical Operational Excellence
Publication date:
Support: Print on demand

232.09 €

In Print (Delivery period: 15 days).

Add to cartAdd to cart
Leading Pharmaceutical Operational Excellence
Publication date:
541 p. · 15.5x23.5 cm · Hardback
Achieving operational excellence is a challenge for the pharmaceutical industry, with many companies setting successful examples time and again. This book presents such leading practices for managing operational excellence throughout the pharmaceutical industry. Based on the St.Gallen OPEX Model the authors describe the current status of OPEX and the future challenges that have to be dealt with. The ample theoretical background is complemented hand-in-hand by case studies contributed by authors from leading pharmaceutical companies.?
Part A - Introduction .- Part B - Leading Operational Excellence - Outstanding Practices.- Part C - Leading Operational Excellence - Outstanding Leadership.- Part D - Gaining the Future.

Thomas Friedli

 

Thomas Friedli is Managing Director at the Chair of Production Management, and Vice Director, Institute of Technology Management, University of St.Gallen (Switzerland). Thomas Friedli’s main research focus is the management of manufacturing enterprises. His area of expertise is in operational excellence in the pharmaceutical industry, collaboration management, management of industrial services and management of global production.

In 2004, Thomas habilitated and became Adjunct Professor in St.Gallen. His team of 12 postgraduate students develops new management solutions for manufacturing companies. The Chair is largely financed through external funds, while most of the research projects are industrial projects. In 2007 he became an associate member to the International Academy for Quality (IAQ) and joined the SAQ (Swiss Association for Quality and Management Systems) as an advisory council in 2009. Since 2010, he is member of the board of the Swiss Institute of Service Sciences (SISS).

Thomas is teaching in several executive programs in St.Gallen, Fribourg, Dornbirn, Salzburg and Aachen; moreover, he is visiting lecturer at the Business School of Bordeaux. In fall 2008, he spent several weeks as Adjunct Associate Professor at the Purdue University in West Lafayette, Indiana, USA. Since 2011, Thomas is Senior Lecturer of the Executive MBA program in St.Gallen and since 2012 also Senior Lecturer of the St.Gallen full time MBA program.

Prabir Basu

Prabir Basu is an independent consultant advising on pharmaceutical manufacturing and cGMP issues. From 2005 till June, 2013, Prabir was the Executive Director of the National Institute for Pharmaceutical Technology and Education (NIPTE) which is currently a non-profit organization supported by 13 leading universities in the U.S. NIPTE’s goal is to address long-term fundamental research and education on the science of pharmaceutical development and manufacturing.

Uses current data about the status and operations of pharmaceutical production Authors from big pharma contribute their own stories in the form of best practice case studies Theoretical backgrounds and practical insights are combined to offer a complete perspective on the industry as well as leadership models Includes supplementary material: sn.pub/extras